Advertisement

Topics

New Agent Promising for Negative Schizophrenia Symptoms

11:05 EDT 4 Aug 2017 | Medscape

In a phase 2b trial, treatment with the investigational agent MIN-101 led to an improvement in negative symptoms of schizophrenia.
Medscape Medical News

Original Article: New Agent Promising for Negative Schizophrenia Symptoms

NEXT ARTICLE

More From BioPortfolio on "New Agent Promising for Negative Schizophrenia Symptoms"

Quick Search
Advertisement
 

Relevant Topic

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...